ArticleMolecular cancer therapeutics2014

Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss.

Ellen M Beauchamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.